Eugene T. Grygielko - Concepedia

Concepedia

Author

Eugene T. Grygielko

GlaxoSmithKline (United States)

Also Known As

E. Grygielko, E.T. Grygielko, EUGENE GRYGIELKO, Eugene Grygielko, Eugene T Grygielko, Eugene T. Grygielko

25

Publications

1.9K

Citations

15

H-Index

67

Concepts

All Affiliations

GlaxoSmithKline (United States)Research Triangle Park Foundation GlaxoSmithKline (United Kingdom)Oregon Health & Science University South College

ET

About

Eugene T. Grygielko is an author at GlaxoSmithKline (United States) specializing in medicine, pharmacology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	14	830
2	Public Health	2	2	185
3	Health Sciences	1	1	150
4	Natural Sciences	1	1	102
5	Social Sciences	1	1	27

Eugene T. Grygielko

×

19

Publications

1.9K

Citations

15

H-Index

	Year	Citations
Inhibition of Transforming Growth Factor (TGF)-β1–Induced Extracellular Matrix with a Novel Inhibitor of the TGF-β Type I Receptor Kinase Activity: SB-431542 Nicholas J. Laping, Eugene T. Grygielko, Anil Mathur, Molecular Pharmacology	2002	647
Oral administration of GW788388, an inhibitor of TGF-β type I and II receptor kinases, decreases renal fibrosis Maj Petersen, Midory Thorikay, Martijn Deckers, Kidney International InflammationFibrosisUrologyKidney ResearchMedicine	2007	213
Inhibition of Gene Markers of Fibrosis with a Novel Inhibitor of Transforming Growth Factor-β Type I Receptor Kinase in Puromycin-Induced Nephritis Eugene T. Grygielko, W. Martin, Christopher Tweed, Journal of Pharmacology and Experimental Therapeutics	2005	186
Novel Rho Kinase Inhibitors with Anti-inflammatory and Vasodilatory Activities Chris P. Doe, Ross Bentley, David J. Behm, Journal of Pharmacology and Experimental Therapeutics	2006	156
Human-induced pluripotent stem cell-derived cardiomyocytes exhibit temporal changes in phenotype Christine Y. Ivashchenko, G. C. Teg Pipes, Irina M. Lozinskaya, American Journal of Physiology-Heart and Circulatory Physiology Cardiac MuscleCardiac Progenitor CellsCardiovascular FunctionFunctional Hips-cmCellular Physiology	2013	150
A Structural and in Vitro Characterization of Asoprisnil: A Selective Progesterone Receptor Modulator Kevin P. Madauss, Eugene T. Grygielko, Su-Jun Deng, Molecular Endocrinology Vitro CharacterizationHormonal ContraceptiveProgesterone ReceptorGynecologyReproductive Biology	2007	148
Discovery of 4-{4-[3-(Pyridin-2-yl)-1<i>H</i>-pyrazol-4-yl]pyridin-2-yl}-<i>N</i>-(tetrahydro-2<i>H</i>- pyran-4-yl)benzamide (GW788388): A Potent, Selective, and Orally Active Transforming Growth Factor-β Type I Receptor Inhibitor Françoise Gellibert, Anne‐Charlotte de Gouville, James M. Woolven, Journal of Medicinal Chemistry ImmunologyReceptor InhibitorPharmacotherapyChemical BiologyPharmaceutical Chemistry	2006	102
Osmolality: a physiological long-term regulator of lumbar sympathetic nerve activity and arterial pressure Karie E. Scrogin, Eugene T. Grygielko, Virginia L. Brooks American Journal of Physiology-Regulatory, Integrative and Comparative Physiology	1999	69
Inhibition of ALK5 Signaling Induces Physeal Dysplasia in Rats Kendall S. Frazier, Roberta Thomas, Marshall S. Scicchitano, Toxicologic Pathology Cell DeathPathologyBmp7 ExpressionOsteoporosisInflammation	2007	47
Estrogen-induced stromal cell-derived factor-1 (SDF-1/Cxcl12) expression is repressed by progesterone and by Selective Estrogen Receptor Modulators via estrogen receptor α in rat uterine cells and tissues Lindsay E. Glace, Eugene T. Grygielko, Ryan Boyle, Steroids Rat Uterine CellsEndocrine MechanismMedicineHormonal ReceptorUterine Receptivity	2009	37

Page 1